The best prompts come from the team.

The smartest way to use AI may not be letting it interact with your files, but asking it to write software that handles them ...

Agoyu integrated its AI moving quote tool into select Realtor.com rental and for-sale listings. Users record a short video of belongings, and the AI estimates weight and volume to deliver real time ...

Some quotes stay popular because they sound clever. Others survive because they feel emotionally true, even years later. This line from Diana, Princess of Wales, belongs firmly in the second category.

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Birgitta Böckeler, Distinguished Engineer at ...

Sam Altman, OpenAI’s CEO and the public face of ChatGPT, has carved out an image for himself as one of the preeminent AI whisperers of our age, whose influence supposedly extends to the White House on ...

The publisher filed a lawsuit in Munich last week, accusing OpenAI of violating copyright laws after ChatGPT allegedly copied a popular German book series, according to The Guardian: In response to ...

Claude Code users have been flooding GitHub and Reddit over the last few days with complaints that their usage limits are being exhausted at a suspiciously fast rate, with many reporting that sessions ...

Amazon is beefing up internal guardrails after recent outages hit the company's e-commerce operation, including one disruption tied to its AI coding assistant Q. Dave Treadwell, Amazon's SVP of ...

The radio signal first started broadcasting on February 28, about 12 hours after the United States and Israel began bombing Iran. On a scratchy shortwave signal almost twice a day -- in the early ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...